US2021032326A1PendingUtilityA1

Methods for the treatment of gout

66
Assignee: XOMA US LLCPriority: Dec 20, 2007Filed: Mar 13, 2020Published: Feb 4, 2021
Est. expiryDec 20, 2027(~1.4 yrs left)· nominal 20-yr term from priority
Inventors:Alan M. Solinger
C07K 2317/24A61P 19/02A61K 2039/505A61P 29/00C07K 2317/21A61K 39/3955C07K 16/245C07K 2317/76A61K 45/06A61P 43/00C07K 2317/34A61P 29/02A61P 19/06C07K 2317/92
66
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed are methods for the treatment and/or prevention of gout, comprising administering to a subject an effective amount of anti-IL-1β antibody or fragment thereof.

Claims

exact text as granted — not AI-modified
1 . A method of treating gout in a subject, the method comprising administering an anti-IL-1β antibody or fragment thereof to the subject. 
     
     
         2 . The method of  claim 1 , wherein the gout is chronic gout. 
     
     
         3 . The method of  claim 1 , wherein the gout is acute gout. 
     
     
         4 - 59 . (canceled)

Join the waitlist — get patent alerts

Track US2021032326A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.